|1.||Nemet, Codruţa: 1 article (01/2007)|
|2.||Fulga, Ion: 1 article (01/2007)|
|3.||Nedelcu, Laurenţiu: 1 article (01/2007)|
|4.||Năşcuţiu, Alexandra-Maria: 1 article (01/2007)|
|5.||Toma, Felicia: 1 article (01/2007)|
|6.||Marcu, Cătălin: 1 article (01/2007)|
|7.||Niţescu, Ruxandra: 1 article (01/2007)|
|8.||Neguţ, Marian: 1 article (01/2007)|
|9.||Grigore, Laura: 1 article (01/2007)|
|10.||Spircu, Tiberiu: 1 article (01/2007)|
01/01/1989 - "Therefore immunosenescence, primarily of T cell functions of old tumor-bearers, may represent a decisive factor influencing the antileukemic, especially curative effect of ambazone in aged animals. "
02/01/1983 - "[Antineoplastic effect of 1,4-benzoquinone guanylhydrazone thiosemicarbazone in experimental tumor models]."
04/01/1990 - "Ambazone (1,4-benzoquinone guanylhydrazone thiosemicarbazone) was found to be active against various transplantable tumors in mice as well as rats. "
01/01/1989 - "Since the antileukemic effect of ambazone disappeared more or less in congenitally athymic nude mice, in neonatally thymectomized or silica-pretreated animals, it has been concluded that the action of the compound seems to be limited to young adult immunocompetent tumor-bearing hosts. "
01/01/1989 - "The immune response against sheep red blood cells (SRBC), a T cell-dependent antigen, was also strongly diminished in tumor-free old mice and was further suppressed after ambazone treatment. "
01/01/1989 - "The antineoplastic activity of 1,4-benzoquinone-guanylhydrazone-thiosemicarbazone (ambazone) against murine leukemia P388 was found to be markedly reduced in 12- and 18-month-old mice as compared to young animals. "
01/01/1990 - "Dihydroambazone 1, a soluble derivative of ambazone, was tested with an admixture of ascorbic acid (0.1, 0.25, or 0.5% in distilled water) for antineoplastic activity by different routes (i.p., p.o., s.c., i.v.) against leukemia P388, and by s.c. "
04/01/1990 - "Ambazone induces an overall increase in the cellular cAMP content of leukemia cells and macrophages. "
01/01/1989 - "A combined treatment with ambazone and immunomodulators (thymalin or a splenopentin derivative) failed to improve the antileukemic effect in young and old leukemia P388-bearing mice."
|1.||Silicon Dioxide (Sand)
|2.||Immunologic Factors (Immunomodulators)
|3.||Ascorbic Acid (Vitamin C)